UAMC | Medicinal Chemistry Research Group Revenue
Research Services • 
Antwerp, Flemish Region, Belgium • 1-10 Employees
UAMC | Medicinal Chemistry Research Group revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at UAMC | Medicinal Chemistry Research Group
Marc Osias
Owner
Company overview
| Headquarters | Universiteitsplein 1, Campus Drie Eiken, Wilrijk, Antwerp 2610, BE |
| Website | |
| NAICS | 5417 |
| Keywords | Inflammation, Infectious Diseases, Medicinal Chemistry, In Silico Drug Design, Autophagy, Cell Death, Ferroptosis, Cell Survival, Necroptosis, Protease Targets |
| Employees | 1-10 |
About UAMC | Medicinal Chemistry Research Group
UAMC is focused on the therapeutic domains of infectious diseases, inflammation, and cell death/survival. The UAMC compounds are mostly targeting enzymes, often proteases. For the discovery of these compounds we use medicinal and computational chemistry approaches, but we are also investing considerably in other techniques such as covalent inhibitors and activity-based probes, bioorthogonal chemistry, bioimaging, fragment-based research such as the modified substrate activity screening (MSAS) developed in house, and on-target synthesis. Our main research topics are: Inflammation; Cell death/survival; In silico drug design; Exploratory pr.otease targets; Infectious diseases; and Technology development.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
UAMC | Medicinal Chemistry Research Group has never raised funding before.
United Kingdom
Australia
Spain
Sweden
Slovenia
Frequently asked questions
4.8
40,000 users
